Pierre Jean-Marie Raboisson

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 22 CIPO patents and 1 EPO patent. Top assignees: Janssen Sciences Ireland Uc, Janssen Products, LP, Janssen Sciences Ireland Unlimited Company. Active years: 2009-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Jean-Marie Raboisson. Retrieved from https://idiyas.com/inventor/pierre-jean-marie-raboisson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 20.0

CIPO Patents = 22 (Patent Applications = 22)

EPO Patents = 1

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 39(Granted Patents)

Location History:

Sterrebeek, BE (2009)
Rosieres, BE (2013 - 2016)
Wavre, BE (2023)

Company Filing History:

2 out of 111

Janssen Sciences Ireland Uc

Janssen Sciences Ireland Unlimited Company

Tibotec Pharmaceuticals Ltd.

patents

where one patent can have more than one assignee

Years Active: 2009-2023

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11597704 - 2,4-diaminoquinazoline derivatives and medical uses thereof (2023-03-07),

2. 9365582 - Macrocyclic inhibitors of hepatitis C virus (2016-06-14),

3. 9233933 - 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis B (2016-01-12),

4. 8481510 - Uracyl spirooxetane nucleosides (2013-07-09),

5. 7514427 - 1,5,6,-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-inflective agents (2009-04-07),

Title: Unveiling the Inventive Mind of Pierre Jean-Marie Raboisson

Introduction:

Pierre Jean-Marie Raboisson, a brilliant inventor from Rosieres, Belgium, has left an indelible mark on the world of innovation with his groundbreaking work.

Latest Patents:

Raboisson's latest patents include the development of 2,4-diaminoquinazoline derivatives for various pharmaceutical applications, such as treating viral infections, virus-induced diseases, cancer, and allergies. Additionally, he has patented macrocyclic inhibitors for combating Hepatitis C virus replication.

Career Highlights:

Throughout his career, Raboisson has accumulated a total of five patents, showcasing his versatility and expertise in the field of pharmaceutical inventions. His work at companies like Janssen Sciences Ireland Uc and Janssen Products, LP has further solidified his reputation as a pioneering inventor.

Collaborations:

Collaborating with esteemed colleagues such as Tim Hugo Maria Jonckers and Koen Vandyck, Raboisson has exemplified the power of teamwork in driving innovation forward. Together, they have worked tirelessly to push the boundaries of scientific discovery.

Conclusion:

In conclusion, Pierre Jean-Marie Raboisson stands out as a beacon of innovation and creativity in the realm of inventors. His dedication to advancing healthcare through inventive solutions is a testament to his unwavering commitment to making a positive impact on the world. Raboisson's legacy will continue to inspire future generations of inventors and innovators to think outside the box and pursue groundbreaking discoveries.

Profile summary based on public USPTO records.